Corbus Pharmaceuticals Holdings, Inc. (CRBP): Price and Financial Metrics

CRBP POWR Grades

• CRBP scores best on the Sentiment dimension, with a Sentiment rank ahead of 92.46% of US stocks.
• CRBP's strongest trending metric is Growth; it's been moving down over the last 179 days.
• CRBP's current lowest rank is in the Momentum metric (where it is better than 4.64% of US stocks).

CRBP Stock Summary

• With a price/sales ratio of 76.71, Corbus Pharmaceuticals Holdings Inc has a higher such ratio than 97.09% of stocks in our set.
• As for revenue growth, note that CRBP's revenue has grown -77.61% over the past 12 months; that beats the revenue growth of only 1.51% of US companies in our set.
• Shareholder yield, a measure of how much is returned to shareholders via dividends and share repurchases, for CRBP comes in at -92.62% -- higher than that of only 4.35% of stocks in our set.
• Stocks that are quantitatively similar to CRBP, based on their financial statements, market capitalization, and price volatility, are CYCN, ONCT, SLDB, ACET, and STRO.
• Visit CRBP's SEC page to see the company's official filings. To visit the company's web site, go to www.corbuspharma.com.

CRBP Valuation Summary

• In comparison to the median Healthcare stock, CRBP's price/sales ratio is 432.16% higher, now standing at 60.4.
• CRBP's price/sales ratio has moved NA NA over the prior 83 months.
• CRBP's price/earnings ratio has moved up 46.2 over the prior 83 months.

Below are key valuation metrics over time for CRBP.

CRBP Growth Metrics

Its 3 year net income to common stockholders growth rate is now at -587.86%.
• The 2 year net income to common stockholders growth rate now stands at -104.29%.
• Its 5 year revenue growth rate is now at 3346.95%.

CRBP's revenue has moved down $1,934,160 over the prior 52 months.

The table below shows CRBP's growth in key financial areas (numbers in millions of US dollars).

Date	Revenue	Operating Cash Flow	Net Income to Common Stock
2021-12-31	0.881705	-48.1837	-45.64043
2021-09-30	1.539909	-56.70543	-43.9916
2021-06-30	2.673207	-84.8155	-76.7108
2021-03-31	2.822995	-93.89405	-97.67775
2020-12-31	3.93723	-99.6857	-111.2694
2020-09-30	5.852546	-104.0233	-129.2382

CRBP's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.

• CRBP has a Quality Grade of C, ranking ahead of 45.96% of graded US stocks.
• CRBP's asset turnover comes in at 0.023 -- ranking 364th of 681 Pharmaceutical Products stocks.
• ARNA, ARWR, and MRSN are the stocks whose asset turnover ratios are most correlated with CRBP.

The table below shows CRBP's key quality metrics over time.